Welliver R C, Sun M, Rinaldo D, Ogra P L
J Pediatr. 1986 Nov;109(5):776-80. doi: 10.1016/s0022-3476(86)80692-8.
To determine whether the magnitude of the respiratory syncytial virus (RSV)-specific IgE response at the time of an episode of RSV bronchiolitis in infancy accurately predicts the development of subsequent wheezing episodes, we observed 38 infants prospectively from the time of an episode of infantile bronchiolitis through 48 months of age. Peak RSV-IgE titers were measured at the time of the bronchiolitis episode using an ELISA procedure. Notation was made of both the number of subsequent wheezing episodes reported by parents and the number documented by a physician. Subsequent wheezing was documented by a physician in 20% of infants who did not develop an RSV-IgE response at the time of the bronchiolitis episode and in 70% of those with the highest responses (P less than 0.025). These results suggest that the magnitude of the RSV-IgE response at the time of RSV bronchiolitis is a useful prognostic indicator for recurrent wheezing.
为了确定婴儿期呼吸道合胞病毒(RSV)细支气管炎发作时RSV特异性IgE反应的强度是否能准确预测随后喘息发作的发生,我们对38名婴儿进行了前瞻性观察,从婴儿期细支气管炎发作时开始,直至48个月龄。在细支气管炎发作时,采用酶联免疫吸附测定(ELISA)法测量RSV-IgE滴度峰值。记录家长报告的以及医生记录的随后喘息发作次数。在细支气管炎发作时未产生RSV-IgE反应的婴儿中,20%有医生记录的随后喘息发作;在反应最强的婴儿中,这一比例为70%(P<0.025)。这些结果表明,RSV细支气管炎发作时RSV-IgE反应的强度是复发性喘息的一个有用的预后指标。